Trends in Health Service Use for Canadian Adults With Dementia and Parkinson Disease During the First Wave of the COVID-19 Pandemic.
Journal
JAMA health forum
ISSN: 2689-0186
Titre abrégé: JAMA Health Forum
Pays: United States
ID NLM: 101769500
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
18
09
2021
accepted:
07
11
2021
entrez:
17
8
2022
pubmed:
18
8
2022
medline:
18
8
2022
Statut:
epublish
Résumé
Persons with dementia and Parkinson disease (PD) are vulnerable to disruptions in health care and services. To examine changes in health service use among community-dwelling persons with dementia, persons with PD, and older adults without neurodegenerative disease during the first wave of the COVID-19 pandemic. Repeated cross-sectional analysis using population-based administrative data among community-dwelling persons with dementia, persons with PD, and adults 65 years and older at the start of each week from March 1 through the week of September 20, 2020 (pandemic period), and March 3 through the week of September 22, 2019 (historical period), in Ontario, Canada. COVID-19 pandemic as of March 1, 2020. Main outcomes were weekly rates of emergency department visits, hospitalizations, nursing home admissions, home care, virtual and in-person physician visits, and all-cause mortality. Poisson regression models were used to calculate weekly rate ratios (RRs) with 95% CIs comparing pandemic weeks with historical levels. Among those living in the community as of March 1, 2020, persons with dementia (n = 131 466; mean [SD] age, 80.1 [10.1] years) were older than persons with PD (n = 30 606; 73.7 [10.2] years) and older adults (n = 2 363 742; 74.0 [7.1] years). While all services experienced declines, the largest drops occurred in nursing home admissions (RR for dementia: 0.10; 95% CI, 0.07-0.15; RR for PD: 0.03; 95% CI, 0.00-0.21; RR for older adults: 0.11; 95% CI, 0.06-0.18) and emergency department visits (RR for dementia: 0.45; 95% CI, 0.41-0.48; RR for PD: 0.40; 95% CI, 0.34-0.48; RR for older adults: 0.45; 95% CI, 0.44-0.47). After the first wave, most services returned to historical levels except physician visits, which remained elevated (RR for dementia: 1.07; 95% CI, 1.05-1.09; RR for PD: 1.10, 95% CI, 1.06-1.13) and shifted toward virtual visits. Older adults continued to experience lower hospitalizations. All-cause mortality was elevated across cohorts. In this population-based repeated cross-sectional study in Ontario, Canada, those with dementia, those with PD, and older adults sought hospital care far less than usual, were not admitted to nursing homes, and experienced excess mortality during the first wave of the pandemic. Most services returned to historical levels, but virtual physician visits remained a feature of care. While issues of equity and quality of care are still emerging among persons with neurodegenerative diseases, policies to support virtual care are necessary.
Identifiants
pubmed: 35977228
doi: 10.1001/jamahealthforum.2021.4599
pii: aoi210077
pmc: PMC8903126
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e214599Informations de copyright
Copyright 2022 Bronskill SE et al. JAMA Health Forum.
Déclaration de conflit d'intérêts
Conflict of Interest Disclosures: Dr Bronskill reported receiving grants from the Ontario Neurodegenerative Disease Research Initiative through the Ontario Brain Institute and Drs Bronskill and Vedel reported receiving a grant from the Canadian Institutes of Health Research (CIHR VR5-172692) during the conduct of the study. Dr Jones and Mr Harris reported postdoctoral and doctoral fellowships, respectively, from the Alzheimer Society of Canada during the conduct of the study. Dr Swartz reported receiving personal fees (administrative stipend) from the Ontario Brain Institute/Ontario Neurodegenerative Disease Research Initiative during the conduct of the study. No other disclosures were reported.
Références
Neurol Sci. 2021 Jul;42(7):2607-2610
pubmed: 33774762
Dementia (London). 2021 Aug;20(6):2007-2023
pubmed: 33381996
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
Alzheimers Dement. 2021 Mar;17(3):327-406
pubmed: 33756057
Pharmacoepidemiol Drug Saf. 2020 Aug;29(8):864-872
pubmed: 32410265
New Solut. 2021 May;31(1):20-29
pubmed: 33451266
J Parkinsons Dis. 2020;10(4):1355-1364
pubmed: 32925108
Health Aff (Millwood). 2020 Nov;39(11):2010-2017
pubmed: 32970495
Am J Emerg Med. 2021 Feb;40:20-26
pubmed: 33338676
Parkinsonism Relat Disord. 2020 Sep;78:21-26
pubmed: 32674024
JAMA Netw Open. 2020 Oct 1;3(10):e2021476
pubmed: 33006622
CMAJ. 2021 May 25;193(21):E753-E760
pubmed: 34035055
Neurol Sci. 2020 Jun;41(6):1373-1375
pubmed: 32363506
BJPsych Open. 2021 May 03;7(3):e91
pubmed: 33938419
JAMA Intern Med. 2021 Apr 1;181(4):439-448
pubmed: 33394006
JAMA Intern Med. 2020 Nov 1;180(11):1453-1459
pubmed: 32749450
J Am Med Dir Assoc. 2020 Jul;21(7):900-904
pubmed: 32674816
Am J Geriatr Psychiatry. 2020 Nov;28(11):1175-1184
pubmed: 32873496
CMAJ Open. 2021 Feb 17;9(1):E107-E114
pubmed: 33597307
Int J Clin Pharm. 2021 Feb;43(1):275-279
pubmed: 32803555
J Am Geriatr Soc. 2020 Aug;68(8):1657-1660
pubmed: 32338767
J Am Med Dir Assoc. 2021 Jul;22(7):1484-1492.e3
pubmed: 33358723
JAMA Intern Med. 2020 Nov 1;180(11):1459-1460
pubmed: 32749452
CMAJ. 2021 May 10;193(19):E672-E680
pubmed: 33972220
CMAJ. 2021 Feb 8;193(6):E200-E210
pubmed: 33558406
BMJ Open. 2021 Feb 5;11(2):e043024
pubmed: 33550257
CMAJ. 2020 Nov 23;192(47):E1540-E1546
pubmed: 32998943
J Am Geriatr Soc. 2020 Jun;68(6):1293-1300
pubmed: 32119121
JAMA Intern Med. 2016 Sep 1;176(9):1371-8
pubmed: 27454945
Int Psychogeriatr. 2020 Nov;32(11):1377-1381
pubmed: 32729446
Health Aff (Millwood). 2020 Oct;39(10):1812-1821
pubmed: 32816600
Br J Cancer. 2020 Oct;123(9):1351-1352
pubmed: 32814836
JAMA Netw Open. 2021 Mar 1;4(3):e211104
pubmed: 33704472
J Parkinsons Dis. 2021;11(3):1047-1056
pubmed: 33780375
Healthc Policy. 2010 Aug;6(1):32-46
pubmed: 21804837
BMJ Open. 2021 Mar 18;11(3):e045813
pubmed: 33737441
Health Aff (Millwood). 2021 Apr;40(4):655-663
pubmed: 33705204
J Alzheimers Dis. 2016 Aug 10;54(1):337-49
pubmed: 27567819
PLoS Med. 2017 Mar 7;14(3):e1002249
pubmed: 28267802
Health Aff (Millwood). 2014 Apr;33(4):658-66
pubmed: 24711328
Curr Opin Neurol. 2021 Aug 1;34(4):589-597
pubmed: 33990100
JAMA Intern Med. 2020 Oct 1;180(10):1328-1333
pubmed: 32744612